Who we are
Designed for Clinical Translation
We integrate proximity biology, machine learning, antibody engineering, and drug development expertise to advance differentiated medicines from discovery into the clinic and through the development process.
Traditional drug discovery has largely focused on individual targets and their expression. We expand this view by examining how proteins are spatially organized within disease-relevant cellular environments.
Our proprietary approach identifies protein neighborhoods that guide therapeutic design, creating opportunities to improve selectivity, expand therapeutic windows, and address limitations of conventional medicines.
Translation & Pipeline Philosophy
InduPro operates an integrated model connecting target discovery directly to therapeutic development and candidate selection.
Our preclinical strategy prioritizes molecules with strong translational potential, guided by target biology, selectivity, and functional validation. By enabling early integration of discovery activities with development strategy, we aim to efficiently advance development-ready candidates into the clinic.
Our pipeline spans multispecific antibodies, antibody-drug conjugates (ADCs), T cell engagers, and other precision therapeutics designed to address significant unmet medical needs.
Focused on clinical translation
Connecting target discovery directly to development-ready therapeutic candidates.
Built on large-scale
proximity datasets
Integrating spatial biology, AI/ML, and antibody engineering to identify differentiated therapeutic opportunities.